Answers are grounded in this paper and cite their sources.
Among the various G protein–mediated intracellular signaling pathways activated by G protein–coupled receptors (GPCRs), Gα s and Gα i stimulate and inhibit adenylyl cyclases (ADCYs), leading to increases and decreases in cAMP abundance, respectively. Here, we investigated the contribution of Gα q -coupled receptors (Gα q -GPCRs), which typically activate phospholipase C (PLC) and stimulate intracellular Ca 2+ generation, to the regulation of cAMP signaling. We activated the endogenous Gα q -coupled muscarinic acetylcholine receptors (Gα q -mAChRs) and the group 1 metabotropic glutamate receptors (mGluR1/5) in ex vivo hippocampal slices from mice. We also used a chemogenetics approach to activate Gα q -DREADDs (designer receptors exclusively activated by designer drugs) through hM3Dq. We found that stimulation of these Gα q -GPCRs not only increased the abundance of cAMP but also activated downstream, cAMP-mediated intracellular signaling pathways. This GPCR-dependent cAMP signaling required both Gα q activity and intracellular Ca 2+ . Additionally, hippocampal slices from mice lacking the Ca 2+ /calmodulin-stimulated ADCYs, ADCY1 and ADCY8, did not exhibit Gα q -GPCR–mediated cAMP signaling and showed impaired synaptic long-term depression (LTD) mediated by Gα q -mAChRs. Together, our findings highlight a nonconventional function of Gα q -GPCRs in regulating cAMP signaling through distinct ADCYs.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: